Global entertainment technology platform delivers strong Q3 year-over-year growth across all key financial metrics, including Revenue (+51%), Gross Margin (+98%) and Adjusted EBITDA (+174%)⁽¹⁾
Network growth accelerates while system signings climb to 120 to-date — more than double what the Company delivered in all of 2022 (47)
Q3 marks the Company's second highest grossing quarter of all time at the global IMAX box office
Box office strength drives significant operating leverage, delivering in the third quarter $12 millionin Net Income, Adjusted EPS⁽¹⁾of $0.35, record Adjusted EBITDA⁽¹⁾of $45 millionand Adjusted EBITDA Margin⁽¹⁾of 47%
Robust cash flow generation continues, with cash from operations of $55 millionthrough nine months, compared with $0.5 millionfor the same period in 2022

NEW YORK, Oct. 25, 2023/PRNewswire/ -- IMAX Corporation(NYSE: IMAX) today reported strong top and bottom-line financial results for the third quarter of 2023, demonstrating the value of its unique global entertainment technology platform and diversified content portfolio.

"IMAX financial results for the third quarter are spectacular by any measure — versus budget, versus our historical performance and in the context of a highly dynamic business environment for media and entertainment," said Richard L. Gelfond, Chief Executive Officer of IMAX. "We are programming by far the strongest and most diverse content portfolio in our history — Hollywoodblockbusters, local language films, marquee theatrical releases by streamers, concert films, docs, Live events – and we couldn't be more pleased with the results across our global network."

"Our outsized performance with Hollywoodblockbusters coupled with the expansion of our successful local language strategy is fueling strong network growth around the world, with robust sales activity in Chinaand North Americaas well as key growth markets across Europeand Southeast Asia."

"It is clear that IMAX is the preferred way to experience blockbuster entertainment globally, and our global footprint, differentiated technology, and asset-lite model have made us a consistent winner. As we enter the fourth quarter, we remain on track to deliver significant growth in system signings, installations, and Adjusted EBITDA for the full year and one of the best years in our history at the global box office."


(1)	Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

Third Quarter Financial Highlights

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
In millions of U.S.Dollars, except per share data	2023		2022		YoY % Change	2023		2022		YoY % Change
Total Revenue	$	103.9	$	68.8	51 %	$	288.8	$	202.8	42 %

Gross Margin	$	62.7	$	31.7	98 %	$	170.7	$	107.5	59 %
Gross Margin (%)	60 %		46 %			59 %		53 %

Net Income (Loss)⁽²⁾	$	12.0	$	(9.0)	N/A	$	22.8	$	(25.4)	N/A
Diluted Net Income (Loss) per share⁽²⁾	$	0.22	$	(0.16)	N/A	$	0.41	$	(0.44)	N/A
Adjusted Net Income (Loss)⁽¹⁾⁽²⁾	$	19.4	$	(3.0)	N/A	$	42.8	$	(7.3)	N/A
Adjusted Net Income (Loss) per share⁽¹⁾⁽²⁾	$	0.35	$	(0.05)	N/A	$	0.77	$	(0.13)	N/A

Adjusted EBITDA per Credit Facility⁽¹⁾⁽³⁾	$	45.1	$	16.5	174 %	$	105.1	$	56.7	85 %
Adjusted EBITDA Margin (%)⁽¹⁾⁽²⁾	47 %		26 %		81 %	39 %		30 %		30 %

Weighted average shares outstanding (in millions):
Basic		54.6		56.0	(3 %)		54.4		57.3	(5 %)
Diluted		55.5		56.0	(1 %)		55.3		57.3	(4 %)


(1)	Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.
(2)	Attributable to common shareholders.
(3)	Adjusted EBITDA per Credit facility attributable to common shareholders.

Third Quarter and September YTD Segment Results⁽¹⁾

	Content Solutions					Technology Products and Services

In millions of U.S.Dollars	Revenue		Gross Margin		Gross Margin %	Revenue		Gross Margin			Gross Margin %
3Q23	$	44.2	$	26.4	60 %	$	56.2		$	33.8	60 %
3Q22		22.0		9.1	42 %		45.5			21.8	48 %
% change	101 %		189 %			23 %			55 %

YTD 3Q23	$	107.6	$	64.4	60 %	$	171.8		$	100.1	58 %
YTD 3Q22		72.5		39.1	54 %	$	126.3			65.9	52 %
% change	48 %		65 %			36 %			52 %


(1)	Please refer to the Company's Form 10-Q for the period ended September 30, 2023, for additional segment information.

Content Solutions Segment

Content Solutions revenues of $44.2 millionincreased 101% year-over-year. Gross box office from IMAX locations in Q3 2023 of $347.1 millionwas up 96% from Q3 2022. Key contributors to third quarter box office performance included:
- Hollywoodtitles led by Oppenheimerwith $180 millionin IMAX GBO with significant contributions coming from Mission Impossible: Dead Reckoning Part 1andIndiana Jones and the Dial of Destiny.
- Local language titles led by the record setting Chinese title Creation of the Gods: Kingdom of Storms($32.3 millionin IMAX GBO), with strong contributions coming from No More Bets, Lost in the Stars, and Jawan.
Gross margin for Content Solutions was $26.4 million(at a 60% margin) and increased 189% compared to the third quarter of the prior year period. This outsized growth was driven by the operating leverage in our business that resulted in very pronounced profit flow-through from box office.

Technology Products and Services Segment

Technology Products and Services revenues and gross margin increased 23% year-over-year to $56.2 millionand 55% year-over-year to $33.8 million, respectively, which reflects growth in box office tied to rental revenues as well as a higher number of sale/hybrid installations.
During the third quarter the Company installed 30 systems compared to 17 systems in the third quarter of 2022. Of those, 16 systems were under sales and hybrid JRSA arrangements, compared to 9 systems in the prior year.

Operating Cash Flow and Liquidity

Net cash provided by operating activities for the nine months through September was $54.6 millioncompared to net cash provided by operating activities of $0.5 millionin the prior year period.

As of September 30, 2023, the Company's available liquidity was $308.9 millionor $438.9 millionexcluding the letter of credit associated with the IMAX China privatization transaction. Our liquidity includes cash and cash equivalents of $109.6 million, $150.0 millionin available borrowing capacity under the Credit Facility, $130.0 millionfor the standby letter of credit and $49.2 millionin available borrowing capacity under IMAX China's revolving facilities. Total debt, excluding deferred financing costs, was $258.2 millionas of September 30, 2023.

In 2021, the Company issued $230.0 millionof 0.500% Convertible Senior Notes due 2026 ("Convertible Notes"). In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750per share of the Company's common shares.

Share Count and Capital Return

The weighted average basic and diluted shares outstanding in the third quarter of 2023 were 54.6 million and 55.5 million, respectively, compared to 56.0 million for both in the third quarter of 2022, a decrease of 3% and 1%, respectively.

The Company repurchased 362,784 common shares at an average price of $16.90per share, for a total of $6.1 million, excluding commission, year-to-date through October 24, 2023.

On June 14, 2023, the Company announced a 3-year extension to its share-repurchase program through June 30, 2026. The current share-repurchase program authorizes the Company to repurchase up to $400 millionof its common shares, of which approximately $187.3 millionremains available.

Supplemental Materials

For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media

On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Tuesday of each week, although the Company may change this timing without notice. Results will be displayed with a few days lag.

The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases, SECfilings and public conference calls and webcasts, for additional information about the Company.

Conference Call

The Company will host a conference call today at 8:30 AM ETto discuss its third quarter 2023 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register here: https://register.vevent.com/register/BI507a09f12d7e4417a07562a7285253bdand you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe. Streaming technology company SSIMWAVE, an IMAX subsidiary, is a leader in AI-driven video quality solutions for media and entertainment companies.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of September 30, 2023, there were 1,731 IMAX systems (1,651 commercial multiplexes, 12 commercial destinations, 68 institutional) operating in 87 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchangeunder the stock code "1970."

IMAX^®, IMAX^®3D, Experience It In IMAX^®, TheIMAX Experience^®, DMR^®, Filmed For IMAX^TM, IMAX Live^TM, IMAX Enhanced®, and SSIMWAVE^®are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

For additional information please contact:

Investors:
IMAX Corporation, New York
Jennifer Horsley
212-821-0154
jhorsley@imax.com

Media:
IMAX Corporation, New York
Mark Jafar
212-821-0102
mjafar@imax.com

Forward-Looking Statements

This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, statements regarding the emergence of Cineworld from bankruptcy, as well as plans and references to the future success of IMAX Corporationtogether with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks related to the adverse impact of the COVID-19 pandemic; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United Statesand Canada, as well as geopolitical conflicts; risks related to the Company's growth and operations in China; the performance of IMAX DMR® films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company's inability to protect the Company's intellectual property; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company's business; risks related to the Company's indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability; the failure to convert system backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in the Company's periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in the Company's most recent Annual Report on Form 10-K, as supplemented by those discussed in the Company's Quarterly Report on Form 10-Q. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Primary Reporting Groups

The Company's Chief Executive Officer ("CEO") is its Chief Operating Decision Maker ("CODM"), as such term is defined under U.S.GAAP. The CODM assesses segment performance based on segment revenues and segment gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Company's segments.

In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources. Accordingly, the Company has two reportable segments: (i) Content Solutions, which principally includes content enhancement and distribution services, previously included within the IMAX DMR, Film Distribution and Film Post-Production segments, and (ii) Technology Products and Services, which principally includes the sale, lease, and maintenance of IMAX Systems, previously included within the JRSA, IMAX Systems, IMAX Maintenance, and Other Theater Business segments. The Company's activities that do not meet the criteria to be considered a reportable segment are reported within All Other. Prior period comparatives have been revised to conform with the current period presentation.

The Company has the following reportable segments:

(i)	Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services.

(ii)	Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

IMAX Network and Backlog

	Three Months Ended September 30,				Nine Months Ended September 30,
System Signings:	2023		2022		2023		2022
New IMAX Systems
Sales and sales-type lease arrangements		7		3		44		9
Hybrid JRSA		—		1		—		3
Traditional JRSA		7		7		32		9
Total new IMAX Systems		14		11		76		21
Upgrades of IMAX systems		6		4		18		14
Total IMAX System signings		20		15		94		35

	Three Months Ended September 30,				Nine Months Ended September 30,
System Installations:	2023		2022		2023		2022
New IMAX Systems
Sales and sales-type lease arrangements		14		7		30		14
Hybrid JRSA		—		2		2		5
Traditional JRSA		4		7		7		16
Total new IMAX Systems		18		16		39		35
Upgrades of IMAX Systems		12		1		20		5
Total IMAX System installations		30		17		59		40

					September 30,
IMAX System Backlog:					2023		2022
Sales and sales-type lease arrangements						192		170
Hybrid JRSA						107		127
Traditional JRSA						187		192
Total IMAX System backlog						486		489

					September 30,
IMAX Network:					2023		2022
Commercial Multiplex Theaters
Sales and sales-type lease arrangements						743		696
Hybrid JRSA						137		150
Traditional JRSA						771		776
Total Commercial Multiplex Theaters						1,651		1,622
Commercial Destination Theaters						12		12
Institutional Theaters						68		69
Total IMAX network						1,731		1,703

IMAX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S.dollars, except per share amounts)
(Unaudited)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2023		2022		2023		2022
Revenues
Technology sales	$	18,273	$	18,065	$	65,455	$	35,270
Image enhancement and maintenance services		60,250		36,233		154,244		117,285
Technology rentals		23,008		12,540		62,612		43,726
Finance income		2,365		1,917		6,510		6,478
		103,896		68,755		288,821		202,759
Costs and expenses applicable to revenues
Technology sales		7,948		10,061		28,951		20,264
Image enhancement and maintenance services		26,646		20,563		69,470		56,259
Technology rentals		6,587		6,430		19,747		18,728
		41,181		37,054		118,168		95,251
Gross margin		62,715		31,701		170,653		107,508
Selling, general and administrative expenses		36,282		32,905		109,336		100,181
Research and development		2,771		1,115		7,388		3,667
Amortization of intangible assets		1,107		1,111		3,328		3,412
Credit loss expense, net		523		808		1,589		8,149
Asset impairments		—		—		—		4,470
Executive transition costs		—		—		1,353		—
Income (loss) from operations		22,032		(4,238)		47,659		(12,371)
Unrealized investment gains		364		35		436		99
Retirement benefits non-service expense		(77)		(140)		(232)		(417)
Interest income		738		257		1,838		1,176
Interest expense		(1,483)		(1,323)		(5,045)		(4,354)
Income (loss) before taxes		21,574		(5,409)		44,656		(15,867)
Income tax expense		(6,555)		(2,348)		(14,901)		(8,091)
Net income (loss)		15,019		(7,757)		29,755		(23,958)
Less: net (income) loss attributable to non-controlling interests		(3,029)		(1,196)		(6,960)		(1,455)
Net income (loss) attributable to common shareholders	$	11,990	$	(8,953)	$	22,795	$	(25,413)

Net income (loss) per share attributable to common shareholders:
Basic	$	0.22	$	(0.16)	$	0.42	$	(0.44)
Diluted	$	0.22	$	(0.16)	$	0.41	$	(0.44)

Weighted average shares outstanding (in thousands):
Basic		54,618		56,039		54,424		57,301
Diluted		55,535		56,039		55,261		57,301

Additional Disclosure:
Depreciation and amortization	$	19,279	$	15,640	$	46,477	$	42,663
Amortization of deferred financing costs	$	492	$	712	$	1,742	$	2,465

IMAX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of U.S.dollars, except share amounts)
(Unaudited)

	September 30,		December 31,
	2023		2022
Assets
Cash and cash equivalents	$	109,603	$	97,401
Accounts receivable, net of allowance for credit losses		135,962		136,142
Financing receivables, net of allowance for credit losses		125,322		129,384
Variable consideration receivables, net of allowance for credit losses		59,042		44,024
Inventories		45,365		31,534
Prepaid expenses		13,042		12,343
Film assets, net of accumulated amortization		5,232		5,277
Property, plant and equipment, net of accumulated depreciation		238,140		252,896
Investment in equity securities		—		1,035
Other assets		20,119		15,665
Deferred income tax assets, net of valuation allowance		11,961		9,900
Goodwill		52,815		52,815
Other intangible assets, net of accumulated amortization		34,343		32,738
Total assets	$	850,946	$	821,154
Liabilities
Accounts payable	$	37,699	$	25,237
Accrued and other liabilities		123,863		117,286
Deferred revenue		66,272		70,940
Revolving credit facility borrowings, net of unamortized debt issuance costs		23,903		36,111
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs		228,449		226,912
Deferred income tax liabilities		13,349		14,900
Total liabilities		493,535		491,386
Commitments, contingencies and guarantees
Non-controlling interests		661		722
Shareholders' equity
Capital stock common shares — no par value. Authorized — unlimited number.
54,607,095 issued and outstanding (December 31, 2022— 54,148,614 issued and outstanding)		390,097		376,715
Other equity		179,970		185,678
Statutory surplus reserve		3,932		3,932
Accumulated deficit		(272,318)		(293,124)
Accumulated other comprehensive loss		(14,637)		(9,846)
Total shareholders' equity attributable to common shareholders		287,044		263,355
Non-controlling interests		69,706		65,691
Total shareholders' equity		356,750		329,046
Total liabilities and shareholders' equity	$	850,946	$	821,154

IMAX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of U.S.dollars)
(Unaudited)

	Nine Months Ended
	September 30,
	2023		2022
Operating Activities
Net income (loss)	$	29,755	$	(23,958)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization		46,477		42,663
Amortization of deferred financing costs		1,742		2,465
Credit loss expense, net		1,589		8,149
Write-downs		872		5,707
Deferred income tax benefit		(3,724)		(3,374)
Share-based and other non-cash compensation		17,830		19,510
Unrealized foreign currency exchange loss		52		1,310
Unrealized investment gains		(436)		(99)
Changes in assets and liabilities:
Accounts receivable		(2,392)		(18,050)
Inventories		(13,771)		(10,131)
Film assets		(14,575)		(14,174)
Deferred revenue		(4,670)		(5,989)
Changes in other operating assets and liabilities		(4,141)		(3,548)
Net cash provided by operating activities		54,608		481
Investing Activities
Purchase of property, plant and equipment		(2,541)		(5,248)
Investment in equipment for joint revenue sharing arrangements		(10,705)		(14,543)
Interest in film classified as a financial instrument		—		(4,731)
Acquisition of other intangible assets		(5,418)		(3,246)
Acquisition of SSIMWAVE, net of cash and cash equivalents acquired		—		(12,639)
Net cash used in investing activities		(18,664)		(40,407)
Financing Activities
Revolving credit facility borrowings		31,032		4,890
Repayments of revolving credit facility borrowings		(43,057)		(3,600)
Credit facility amendment fees paid		—		(2,277)
Other borrowings		315		—
Repurchase of common shares		(4,263)		(53,581)
Repurchase of common shares, IMAX China		—		(3,043)
Taxes withheld and paid on employee stock awards vested		(6,458)		(3,393)
Principal payment under finance lease obligations		(480)		(890)
Dividends paid to non-controlling interests		(1,438)		(2,701)
Net cash used in financing activities		(24,349)		(64,595)
Effects of exchange rate changes on cash		607		1,961
Increase (decrease) in cash and cash equivalents during period		12,202		(102,560)
Cash and cash equivalents, beginning of period		97,401		189,711
Cash and cash equivalents, end of period	$	109,603	$	87,151

*Segment Revenue and Gross Margin*

	Three Months Ended				Nine Months Ended
	September 30,					September 30,
(In thousands of U.S.Dollars)	2023		2022			2023		2022
Revenue
Content Solutions	$	44,214	$	21,967		$	107,605	$	72,499
Technology Products and Services		56,169		45,542			171,813		126,262
Sub-total for reportable segments		100,383		67,509			279,418		198,761
All Other⁽¹⁾		3,513		1,246			9,403		3,998
Total	$	103,896	$	68,755		$	288,821	$	202,759

Gross Margin
Content Solutions	$	26,407	$	9,140		$	64,397	$	39,121
Technology Products and Services		33,761		21,752			100,066		65,875
Sub-total for reportable segments		60,168		30,892			164,463		104,996
All Other⁽¹⁾		2,547		809			6,190		2,512
Total	$	62,715	$	31,701		$	170,653	$	107,508


(1)	All Other includes the results from the Company's streaming and consumer technology business, as well as other ancillary activities.

IMAX CORPORATION
NON-GAAP FINANCIAL MEASURES
(in thousands of U.S.dollars)

In this release, the Company presents adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company's performance, which are not recognized under U.S.GAAP. Adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) COVID-19 government relief benefits, net, (iii) realized and unrealized investment gains or losses; (iv) transaction-related expenses, and (v) executive transition costs, as well as the related tax impact of these adjustments.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income (loss) attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share are presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as well as "Adjusted EBITDA per Credit Facility," as defined in the Company's Credit Agreement. As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements, when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.

EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; (iv) executive transition costs; and (v) write-downs, net of recoveries, including asset impairments and credit loss expense.

A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

In this release, the Company also presents free cash flow, which is not recognized under U.S.GAAP, as a supplemental measure of the Company's liquidity. The Company's definition of free cash flow deducts only normal recurring capital expenditures, including its investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

*Adjusted EBITDA per Credit Facility*

	For the Three Months Ended September 30, 2023						For the Three Months Ended September 30, 2022
	Attributable to						Attributable to
	Non-controlling		Less:				Non-controlling		Less:
	Interests and		Attributable to		Attributable to		Interests and		Attributable to		Attributable to
	Common		Non-controlling		Common		Common		Non-controlling		Common
(In thousands of U.S.Dollars)	Shareholders		Interests		Shareholders		Shareholders		Interests		Shareholders
Reported net income (loss)	$	15,019	$	3,029	$	11,990	$	(7,757)	$	1,196	$	(8,953)
Add (subtract):
Income tax expense		6,555		1,041		5,514		2,348		(22)		2,370
Interest expense, net of interest income		253		(145)		398		354		(39)		393
Depreciation and amortization, including film asset amortization		19,279		1,304		17,975		15,640		1,214		14,426
Amortization of deferred financing costs⁽¹⁾		492		—		492		712		—		712
EBITDA	$	41,598	$	5,229	$	36,369	$	11,297	$	2,349	$	8,948
Share-based and other non-cash compensation		5,297		155		5,142		5,544		(27)		5,571
Unrealized investment gains		(364)		(93)		(271)		(35)		—		(35)
Transaction-related expenses		3,086		—		3,086		955		—		955
Write-downs, including asset impairments and credit loss expense		921		164		757		1,083		66		1,017
Adjusted EBITDA per Credit Facility	$	50,538	$	5,455	$	45,083	$	18,844	$	2,388	$	16,456
Revenues attributable to common shareholders⁽²⁾	$	103,896	$	8,028	$	95,868	$	68,755	$	4,257	$	64,498
Adjusted EBITDA margin attributable to common shareholders	49 %		68 %		47 %		27 %		56 %		26 %

	For the Twelve Months Ended September 30, 2023						For the Twelve Months Ended September 30, 2022
	Attributable to						Attributable to
	Non-controlling		Less:				Non-controlling		Less:
	Interests and		Attributable to		Attributable to		Interests and		Attributable to		Attributable to
	Common		Non-controlling		Common		Common		Non-controlling		Common
(In thousands of U.S.Dollars)	Shareholders		Interests		Shareholders		Shareholders		Interests		Shareholders
Reported net income (loss)	$	33,836	$	8,428	$	25,408	$	(10,579)	$	4,734	$	(15,313)
Add (subtract):
Income tax expense		16,917		2,658		14,259		19,239		2,027		17,212
Interest expense, net of interest income		2,024		(286)		2,310		970		(327)		1,297
Depreciation and amortization, including film asset amortization		60,475		5,260		55,215		58,175		5,056		53,119
Amortization of deferred financing costs⁽¹⁾		2,454		—		2,454		3,229		—		3,229
EBITDA	$	115,706	$	16,060	$	99,646	$	71,034	$	11,490	$	59,544
Share-based and other non-cash compensation		25,893		835		25,058		27,031		845		26,186
Unrealized investment gains		(407)		(93)		(314)		(128)		—		(128)
Transaction-related expenses		3,408		—		3,408		955		—		955
Write-downs, including asset impairments and credit loss expense		4,328		561		3,767		15,675		1,538		14,137
Executive transition costs		1,353		—		1,353		—		—		—
Adjusted EBITDA per Credit Facility	$	150,281	$	17,363	$	132,918	$	114,567	$	13,873	$	100,694
Revenues attributable to common shareholders⁽²⁾	$	386,867	$	28,260	$	358,607	$	311,331	$	24,347	$	286,984
Adjusted EBITDA margin attributable to common shareholders	39 %		61 %		37 %		37 %		57 %		35 %

	Three months ended					Three months ended					Twelve months ended					Twelve months ended
(In thousands of U.S.Dollars)	September 30, 2023					September 30, 2022					September 30, 2023					September 30, 2022
Total revenues				$	103,896				$	68,755				$	386,867				$	311,331
Greater Chinarevenues	$		28,297			$		14,889			$		99,703			$		84,769
Non-controlling interest ownership percentage⁽³⁾		28.37 %					28.59 %					28.34 %					28.72 %
Deduction for non-controlling interest share of revenues					(8,028)					(4,257)					(28,260)					(24,347)
Revenues attributable to common shareholders				$	95,868				$	64,498				$	358,607				$	286,984


(3)	Weighted average ownership percentage for change in non-controlling interest share.

*Adjusted Net Income (Loss) Attributable to Common Shareholders and Adjusted Net Income (Loss) Per Share*

	Three Months Ended September 30,
	2023				2022
(In thousands of U.S.Dollars, except per share amounts)	Net Income		Per Share		Net Loss		Per Share
Net income (loss) attributable to common shareholders	$	11,990	$	0.22	$	(8,953)	$	(0.16)
Adjustments⁽¹⁾:
Share-based compensation		5,063		0.09		5,431		0.10
COVID-19 government relief benefits, net		—		—		(212)		—
Unrealized investment gains		(454)		(0.01)		(34)		—
Transaction-related expenses		3,086		0.06		955		0.02
Tax impact on items listed above		(275)		—		(214)		—
Adjusted net income (loss)⁽¹⁾	$	19,410	$	0.35	$	(3,027)	$	(0.05)

Weighted average shares outstanding — basic				54,618				56,039
Weighted average shares outstanding — diluted				55,535				56,039

	Nine Months Ended September 30,
	2023				2022
(In thousands of U.S.dollars, except per share amounts)	Net Income		Per Share		Net Loss		Per Share
Net income (loss) attributable to common shareholders	$	22,795	$	0.41	$	(25,413)	$	(0.44)
Adjustments⁽¹⁾:
Stock-based compensation		17,110		0.31		18,651		0.33
COVID-19 government relief benefits, net		—		—		(373)		(0.01)
Unrealized investment gains		(526)		(0.01)		(98)		—
Transaction-related expenses		3,242		0.06		955		0.02
Executive transition costs		1,353		0.02		—		—
Tax impact on items listed above		(1,184)		(0.02)		(1,071)		(0.02)
Adjusted net income (loss)⁽¹⁾	$	42,790	$	0.77	$	(7,349)	$	(0.13)

Weighted average shares outstanding — basic				54,424				57,301
Weighted average shares outstanding — diluted				55,261				57,301


(1)	Reflects amounts attributable to common shareholders.

*Free Cash Flow*

	Nine Months Ended		Nine Months Ended
(In thousands of U.S.Dollars)	September 30, 2023		September 30, 2022
Net cash provided by operating activities	$	54,608	$	481
Net cash used in capital expenditures		(18,664)		(23,037)
Free cash flow	$	35,944	$	(22,556)

View original content to download multimedia:https://www.prnewswire.com/news-releases/imax-corporation-reports-record-q3-2023-results-301966689.html

SOURCE IMAX Corporation

The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

Revenues attributable to common shareholders calculated as follows: